Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)
Haowen Tang(Chinese PLA General Hospital), Chaoliu Dai(Technical University of Munich), Zhiyong Huang(Tongji Hospital), Daobing Zeng(Capital Medical University), Maoqiang Wang(Chinese PLA General Hospital), Shouwang Cai(Chinese PLA General Hospital), Chengang Li(Chinese PLA General Hospital), Wanguang Zhang(Tongji Hospital), Jie Gao(Peking University), Ziman Zhu(China Three Gorges University), Minggen Hu(Chinese PLA General Hospital), Xinyu Bi(Chinese Academy of Medical Sciences & Peking Union Medical College), Nian-Xin Xia(Chinese PLA General Hospital), Xiaodong Tian(Peking University), Shunda Du(Academy of Medical Sciences), Wenbing Sun(Capital Medical University), Kaishan Tao(Xijing Hospital), Yinying Lu(Chinese PLA General Hospital), Yinzhe Xu(Ningxia Water Conservancy), Fei Li(Capital Medical University), Junning Cao(Fudan University Shanghai Cancer Center), Qinghua Meng(GlaxoSmithKline (China)), Bin Liang(Chinese PLA General Hospital), Zhao-Hai Wang(Qingdao University), Haitao Zhao(Huaiyin Normal University), Wenbin Ji(Tianjin Medical University General Hospital), Chunyi Hao(Peking University), Dongdong Lin(Chinese Academy of Medical Sciences & Peking Union Medical College), Ze Zhang(Harvard University), Kai Li(Institute of Quality Standards and Testing Technology for Agro Products), Wenwen Zhang(Binzhou Medical University), Zhiqiang Wang, Zhijun Wang(Zhejiang A & F University), Zhe Liu(Dalian Medical University), Wenheng Zheng(Liaoning Cancer Hospital & Institute), Ren Lang(Beijing Chao-Yang Hospital, Capital Medical University), Hongguang Wang(Chongqing University), Jun Liang(Hebei Medical University), Baocai Xing(Ministry of Education), Jun Zhou(Anhui Medical University), Yongwei Chen(Sun Yat-sen University), Jushan Wu(Capital Medical University), Jiye Zhu(Peking University), Li Gong(Xi'an Medical University), Feng Duan(Chinese PLA General Hospital), Tao Wan(Chinese PLA General Hospital), Binwei Duan(Capital Medical University), Yongping Yang(Second People’s Hospital of Yibin), Keming Zhang(Second Military Medical University), Yinbiao Cao(Chinese PLA General Hospital)
Cited by 20
Related Papers
Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs)
|Cellular Physiology and Biochemistry|2017|2.8k
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|436